Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey
- PMID: 3276735
- PMCID: PMC329604
- DOI: 10.1172/JCI113354
Lipoprotein metabolism during acute inhibition of lipoprotein lipase in the cynomolgus monkey
Abstract
To clarify the role of lipoprotein lipase (LPL) in the catabolism of nascent and circulating very low density lipoproteins (VLDL) and in the conversion of VLDL to low density lipoproteins (LDL), studies were performed in which LPL activity was inhibited in the cynomolgus monkey by intravenous infusion of inhibitory polyclonal or monoclonal antibodies. Inhibition of LPL activity resulted in a three- to fivefold increase in plasma triglyceride levels within 3 h. Analytical ultracentrifugation and gradient gel electrophoresis demonstrated an increase predominantly in more buoyant, larger VLDL (Sf 400-60). LDL and high density lipoprotein (HDL) cholesterol levels fell during this same time period, whereas triglyceride in LDL and HDL increased. Kinetic studies, utilizing radiolabeled human VLDL, demonstrated that LPL inhibition resulted in a marked decrease in the catabolism of large (Sf 400-100) VLDL apolipoprotein B (apoB). The catabolism of more dense VLDL (Sf 60-20) was also inhibited, although to a lesser extent. However, there was a complete block in the conversion of tracer in both Sf 400-100 and 60-20 VLDL apoB into LDL during LPL inhibition. Similarly, endogenous labeling of VLDL using [3H]leucine demonstrated that in the absence of LPL, no radiolabeled apoB appeared in LDL. We conclude that although catabolism of dense VLDL continues in the absence of LPL, this enzyme is required for the generation of LDL.
Similar articles
-
Role of lipoprotein lipase in the regulation of high density lipoprotein apolipoprotein metabolism. Studies in normal and lipoprotein lipase-inhibited monkeys.J Clin Invest. 1990 Aug;86(2):463-73. doi: 10.1172/JCI114732. J Clin Invest. 1990. PMID: 2117022 Free PMC article.
-
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey.J Clin Invest. 1982 Dec;70(6):1184-92. doi: 10.1172/jci110717. J Clin Invest. 1982. PMID: 7174789 Free PMC article.
-
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.J Clin Invest. 1986 Nov;78(5):1287-95. doi: 10.1172/JCI112713. J Clin Invest. 1986. PMID: 3095375 Free PMC article.
-
Lipoprotein heterogeneity and apolipoprotein B metabolism.Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3542-56. doi: 10.1161/01.atv.17.12.3542. Arterioscler Thromb Vasc Biol. 1997. PMID: 9437204 Review.
-
Adrenergic effects on plasma lipoprotein metabolism. Speculation on mechanisms of action.Am J Med. 1986 Feb 14;80(2A):71-81. doi: 10.1016/0002-9343(86)90163-4. Am J Med. 1986. PMID: 3080883 Review.
Cited by
-
2017 George Lyman Duff Memorial Lecture: Fat in the Blood, Fat in the Artery, Fat in the Heart: Triglyceride in Physiology and Disease.Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):700-706. doi: 10.1161/ATVBAHA.117.309666. Epub 2018 Feb 1. Arterioscler Thromb Vasc Biol. 2018. PMID: 29419410 Free PMC article. Review.
-
Effect of a high-carbohydrate, low-saturated-fat diet on apolipoprotein B and triglyceride metabolism in Pima Indians.J Clin Invest. 1990 Aug;86(2):642-50. doi: 10.1172/JCI114756. J Clin Invest. 1990. PMID: 2200808 Free PMC article.
-
Influence of apolipoprotein E polymorphism on apolipoprotein B-100 metabolism in normolipemic subjects.J Clin Invest. 1991 Nov;88(5):1490-501. doi: 10.1172/JCI115459. J Clin Invest. 1991. PMID: 1939641 Free PMC article.
-
Inhibition of endothelial lipase causes increased HDL cholesterol levels in vivo.J Clin Invest. 2003 Feb;111(3):357-62. doi: 10.1172/JCI16146. J Clin Invest. 2003. PMID: 12569161 Free PMC article.
-
Independent relationships of daily life activity and leisure-time exercise with metabolic syndrome and its traits in the general Japanese population.Endocrine. 2019 Jun;64(3):552-563. doi: 10.1007/s12020-019-01926-9. Epub 2019 Apr 22. Endocrine. 2019. PMID: 31011988
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous